A point mutation in SCN1A 5′ genomic region decreases the promoter activity and is associated with mild epilepsy and seizure aggravation induced by antiepileptic drug
A point mutation in SCN1A 5′ genomic region decreases the promoter activity and is associated with mild epilepsy and seizure aggravation induced by antiepileptic drug
复制标题
DOI：
10.1007/s12035-016-9800-y
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Yi-Wu Shi
中科院分区：
文献类型：
--
作者：
Qu-Wen Gao;Li-Dong Hua;Jie Wang;Cui-Xia Fan;Wei-Yi Deng;Bin Li;Wen-Jun Bian;Chuan-Xing Shao;Na He;Peng Zhou;Wei-Ping Liao;Yi-Wu Shi
